Fertility Monitors Market is segmented By Type (Ovulation Predictor Monitor, Urine & Saliva-based Monitor, Others), By Product (Table, Hand-Held), By Indication (Female Fertility Testing, Male Fertility Testing), By End-User (Fertility Clinics, Hospitals, Homecare, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2023-2030.
Fertility monitors market is estimated to reach at a CAGR 7.7% over the forecast period (2023-2030).
A fertility monitor is an electronic device that helps identify the fertile period. They are generally small, portable, battery-operated gadgets that analyse the results of a fertility test.
Market Dynamics
Technological advancement for fertility awareness among people is expected to drive market growth.
Sensor-enabled Internet of Things (IoT) device development. On the one hand, these have been primarily connected with menstrual (self-)tracking applications in ways that make menstrual tracking applications appear to focus on fertility or contraception, extend understandings of the menstrual cycle or increase menstrual literacy. In contrast to how these technologies could exist differently in ways that encourage self-knowledge and affirm and support the needs of different kinds of menstruating bodies, such an instrumental approach to menstruation prescribes the forms of knowledge and types of relationships with their body that those who menstruate are regarded as likely to embrace, these technologies could exist differently in ways that encourage self-knowledge and affirm and support the needs of different kinds of menstruating bodies. Generally, these technologies seek to support conception. Individuals can record menstruation and bodily signs of ovulation with the promise of producing more detailed knowledge of the individual's menstrual cycle and predictions of their most fertile days or fertile window in the cycle. Thus, it is expected to drive market growth in the forecast period.
Drawbacks associated with fertility monitors are expected to hamper market growth.
Ovulation predictor kits (OPK) or higher-tech devices can be pricey, daily monitoring (through Basal Body Temperature (BBT) or during the follicular phase with OPK's) can add to fertility stress, and possibly false or unclear results are some of the factors due to which the market is expected to hamper the market growth.
COVID-19 Impact Analysis
The COVID-19 pandemic has moderately impacted healthcare systems and the market. Globally, infections with novel SARS-CoV-2 virus continuously rise with mounting numbers of deaths. The ACE2 receptor is found in both the female and male reproductive systems, and reports of multi-organ involvement have raised questions about the receptor's implications on fertility. SARS-CoV-2 infection may affect ovarian function and thus egg quality due to ACE2 in the ovaries. Higher ACE2 expression in the endometrium with age and throughout the secretory phase raises concerns about increased infection susceptibility at these times.
Moreover, evidence of orchitis and hormonal changes seen in male coronavirus disease 2019 infection may lead to infertility. Therefore, it has increased the demand for fertility monitors. But, the pandemic interrupted the medical supply chain, and many companies will vary to other geographic regions in the future to ensure that products remain available and protect their supply chain. However, the situation is expected to improve gradually in the forecast period.
Segmentation Analysis
Ovulation Predictor Monitor segment is expected to hold the largest market share in fertility monitors market
The ovulation predictor monitor segment is expected to dominate in 2020. The segment is benefited because Ovulation test strips can determine the most fertile days. Depending on your menstrual cycle, they can have an accuracy rate of up to 99 percent. Ovulation test strips are designed to detect luteinizing hormone (LH) levels in urine. This hormone signals ovulation, which releases an egg from the ovaries into the fallopian tube. Moreover, Home ovulation testing appears to be an acceptable intervention that can increase pregnancy rates, improve reproductive health knowledge and encourage shared decision-making for couples attempting to achieve pregnancy. Therefore, it has increased the demand for ovulation predictor monitors, due to which the market segment is expected to hold the largest market share in the forecast period.
Market Scope
|
Metrics |
Details |
|
Market CAGR |
7.7% |
|
Segments Covered |
By Type, By Product, By Indication, By End-User, and By Region |
|
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
|
Fastest Growing Region |
Asia Pacific |
|
Largest Market Share |
North America |
Geographical Analysis
North America region holds the largest market share in the global fertility monitors market
In 2020, North America accounted for the highest revenue share. The increasing prevalence of infertility cases, technological advancement in fertility monitors, the surge in inpatient visits to gynecologists, owing to high healthcare expenditure, product launches by the market players in the region are expected to boost the market in the forecast period. For instance, approximately one in eight couples are affected by infertility in the United States. That's about 6.7 million people each year who have trouble conceiving. Moreover, according to the Centers for Disease Control and Prevention, in 2020, 30% of infertility cases can be attributed solely to the female, 30% can be attributed solely to the male, 30% can be attributed to a combination of both partners, and 10% of cases have an unknown cause.
Additionally, Inito has launched a newly developed at-home fertility test in the U.S. market. It works by measuring estrogen and luteinizing hormone levels to predict fertile days, then measuring progesterone to confirm ovulation, ultimately assisting patients through conception. Therefore, it has increased the demand for fertility monitors, due to which the North American region is expected to hold the largest market share in the forecast period.
Competitive Landscape
Major key players in the fertility monitors market are Swiss Precision Diagnostics GmbH, UEBE Medical GmbH, Valley Electronics AG, Comper Healthcare, EarlySense, Bistos Co., Ltd, viO HealthTech Limited and Raiing Medical Company.
Comper Healthcare:
Overview:
Comper, founded in Silicon Valley, is a nation-level high-tech brand providing precise in-house healthcare services. Comper has an outstanding R&D team, with a rigorous human data model, independently designed, developed and manufactured accurate and easy-to-use intelligent health products. Comper strives to become the world's No.1 family health hardware brand, enabling people to intelligently and comprehensively monitor their body data.
Product Portfolio:
MyLab™9VET
MyLab™9VET
MyLab™9VET
MyLab™9VET
Comper Smart Doppler Fetal Monitor: A reinvented handheld ultrasound Doppler fetal heart rate monitor, which monitors and analyses heart rate to ensure fetal development during pregnancy, should any abnormalities occur, take timely action.
